MedPath
NMPA Approval

Varenicline Tartrate Nasal Spray

国药准字HJ20240138

November 22, 2024

Drug Information

酒石酸伐尼克兰鼻喷雾剂

鼻用制剂

4.2ml:2.5mg(按C₁₃H₁₃N₃计),60喷,每喷0.03mg(按C₁₃H₁₃N₃计)。

化学药品

November 22, 2024

November 21, 2029

Company Information

Applicant Company

202 Carnegie Center, Suite 106, Princeton, NJ 08540 United States of America

Manufacturing Company

1200 Paco Way, Lakewood, NJ 08701 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸伐尼克兰鼻喷雾剂 - NMPA 批准文号 | MedPath